Your LCRF Spring newsletter is here!
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌       

 

Summer 2019
Uncovering the possibilities of personalized medicine through research
Dr. Trudy Oliver, a 2018 LCRF research grant recipient, shared her thoughts about how research discoveries are changing the options that are available to patients with lung cancer.
MEET DR. OLIVER
 
Exciting news for LCRF research grant program
2019 is a VERY exciting year for LCRF’s research grant program – we have added two new funding mechanisms this year alone! LCRF recently announced the awardees of our 2019 research grant focused on lung cancer disparities, and we will be supporting three projects focused on the management of targeted therapy side effects for non-small cell lung cancer patients. Stay tuned to hear additional details about our 2019 research grants in the fall.
FIND OUT MORE
 
New Scientific Advisory Board chair
Two-time LCRF grant recipient, Dr. Katerina Politi, has been named the chair of LCRF's Scientific Advisory Board, taking over the role for Dr. James B. Dougherty. Dougherty, who held the chair position for 14 years, has been instrumental in the growth of LCRF and our grant program.
READ MORE
 
Make an impact in one minute
Sharing your hopes for the future of lung cancer can inspire others to get involved and support research. Pick up your phone and record a one-minute video of yourself talking about your connection to the lung cancer community. Why is funding lung cancer research important to you? Why do you want everyone to be free to breathe? Use the hashtags #lcrf and #freetobreathe, and tag us @lungcancerresearchfoundation on Facebook or Instagram; @lcrf_org on Twitter.
SEE AN EXAMPLE

Let's hear it for... Amy Norton, a lung nurse navigator from Sarah Cannon Cancer Institute in Kansas, is spearheading the organization's first ever golf tournament, with proceeds benefiting the Kansas City Free to Breathe Walk.
Send your shoutouts to news@lcrf.org!

FDA Approves SCLC Treatment
On June 17, 2019, the Food and Drug Administration (FDA) approved immunotherapy drug pembrolizumab (Keytruda) for second or third-line treatment of patients with metastatic small cell lung cancer (SCLC).
LEARN MORE
Team LCRF Takes New York!
We’ve got some BIG news! Nine runners will be representing LCRF on November 3 at the TCS New York City Marathon! Learn about these athletes and why they’re motivated to run 26.2 miles with Team LCRF!
MEET THE RUNNERS
Upcoming events
 
Aug 11
Strides for Life, Southampton Cultural Center, Southampton, NY
 
Sept 15
Chelmsford Free to Breathe Walk, Chelmsford, MA
 
Sept 21
Central Iowa Free to Breathe Walk, West Des Moines, IA
Kansas City Free to Breathe Walk, Olathe, KS
 
Sept 22
Chicago Lung Run, Chicago, IL
 
View full schedule of events
 
'Cancer picked the wrong girl!'
Felicia suffered with breathing issues and spent three days in the ICU, but her symptoms weren't improving. When she finally had a scan, it revealed a fist-sized tumor. "I felt like my whole world had crashed," she said.
READ HER STORY

 

DONATE TO SUPPORT LUNG CANCER RESEARCH!
 
 

LCRF logo

Donate | Unsubscribe | View E-News Online

Lung Cancer Research Foundation, 155 E 55th St, Suite 6H, New York, NY 10022
lcrf.org | news@lcrf.org | ©2019

   
 
                                                           
powered by Blackbaud
nonprofit software